Biomarin Pharmaceutical reported $4.39B in Equity Capital and Reserves for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 444.8M 96.1M
Acorda Therapeutics ACOR:US $ 127.55M 23.59M
Agios Pharmaceuticals AGIO:US $ 1207.45M 84.52M
Alnylam Pharmaceuticals ALNY:US $ 401.17M 187.04M
Amgen AMGN:US $ 916M 5784M
Bayer BAYN:GR € 33020M 1917M
Biomarin Pharmaceutical BMRN:US $ 4391.31M 120.58M
Bluebird Bio BLUE:US $ 374.28M 496.25M
Insmed INSM:US $ 119.88M 290.59M
IONIS PHARMACEUT IONS:US $ 709.57M 62.16M
Sangamo Biosciences SGMO:US $ 334.52M 40.82M